LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
-0.87%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.6B
AUM Growth
+$3.6B
(+51%)
Cap. Flow
+$1.29B
Cap. Flow
% of AUM
35.88%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
429
New
62
Increased
58
Reduced
52
Closed
147
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$186M |
| 2 |
Amazon
AMZN
|
$149M |
| 3 |
Microsoft
MSFT
|
$145M |
| 4 |
Target
TGT
|
$116M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$108M |
Top Sells
| 1 |
Warner Bros
WBD
|
$213M |
| 2 |
Lowe's Companies
LOW
|
$159M |
| 3 |
T-Mobile US
TMUS
|
$118M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$39.2M |
| 5 |
Texas Instruments
TXN
|
$37.5M |
Sector Composition
| 1 | Healthcare | 17.93% |
| 2 | Communication Services | 17.3% |
| 3 | Financials | 14.67% |
| 4 | Technology | 14.6% |
| 5 | Consumer Discretionary | 14.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Viking Therapeutics
VKTX
$3.02B
| $3.53M | 0.02% |
1,299,000
-24,809
| -2% | -$67.5K |
|
102
PNC Financial Services
PNC
$80.7B
| $3.49M | 0.02% |
23,323
+21,133
| +965% | +$3.16M |
|
103
Vor Biopharma
VOR
$253M
| $3.41M | 0.02% |
857,308
| – | – |
|
104
Dow Inc
DOW
$17B
| $3.33M | 0.02% |
75,696
-1,200
| -2% | -$52.7K |
|
105
Lyft
LYFT
$7.02B
| $3.28M | 0.02% |
+248,602
| New | +$3.28M |
|
106
UroGen Pharma
URGN
$896M
| $3.17M | 0.02% |
380,600
| – | – |
|
107
Wave Life Sciences
WVE
$1.27B
| $3.15M | 0.02% |
871,500
| – | – |
|
108
Entrada Therapeutics
TRDA
$202M
| $3.14M | 0.02% |
199,066
+70,000
| +54% | +$1.1M |
|
|
AKUS
109
DELISTED
Akouos, Inc. Common Stock
AKUS
| $3.08M | 0.02% |
456,000
| – | – |
|
|
VIRX
110
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.98M | 0.02% |
698,000
| – | – |
|
111
Fortinet
FTNT
$58.7B
| $2.97M | 0.02% |
60,513
-33,873
| -36% | -$1.66M |
|
112
Thermo Fisher Scientific
TMO
$183B
| $2.83M | 0.02% |
5,570
+3,603
| +183% | +$1.83M |
|
113
Arrowhead Research
ARWR
$3.84B
| $2.78M | 0.02% |
84,095
-1,033
| -1% | -$34.1K |
|
114
Lineage Cell Therapeutics
LCTX
$281M
| $2.69M | 0.02% |
2,377,940
-44,427
| -2% | -$50.2K |
|
115
Caterpillar
CAT
$194B
| $2.58M | 0.02% |
15,723
-16,887
| -52% | -$2.77M |
|
116
Marsh & McLennan
MMC
$101B
| $2.57M | 0.02% |
+17,184
| New | +$2.57M |
|
117
Applied Materials
AMAT
$124B
| $2.54M | 0.02% |
31,030
+28,178
| +988% | +$2.31M |
|
118
Parker-Hannifin
PH
$94.8B
| $2.52M | 0.01% |
+10,410
| New | +$2.52M |
|
119
Boston Scientific
BSX
$159B
| $2.52M | 0.01% |
64,949
+168
| +0.3% | +$6.51K |
|
120
IBM
IBM
$227B
| $2.48M | 0.01% |
20,845
+18,344
| +733% | +$2.18M |
|
121
Werewolf Therapeutics
HOWL
$62.6M
| $2.36M | 0.01% |
522,900
-12,260
| -2% | -$55.3K |
|
|
ICVX
122
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $2.35M | 0.01% |
742,354
| – | – |
|
|
OMGA
123
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $2.35M | 0.01% |
432,700
| – | – |
|
124
CrowdStrike
CRWD
$104B
| $2.31M | 0.01% |
14,000
+8,900
| +175% | +$1.47M |
|
125
Marriott International Class A Common Stock
MAR
$72B
| $2.26M | 0.01% |
+16,150
| New | +$2.26M |
|